Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Adequate steroid treatment needed to limit bone loss in PMR patients.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Prolonged use of topical corticosteroids can cause excessive hair growth.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Neurosteroids play a key role in controlling the brain-adrenal gland activity in pregnant sheep, both in normal and stressful situations.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Skin hormone levels change significantly after menopause.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

NonClassic Congenital Adrenal Hyperplasia is a less severe form of a genetic disorder affecting adrenal gland function.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

New compounds were made that effectively block a specific enzyme related to androgen conditions.